Pharmaceuticals Industry Strategy Group final report

The changing global environment presents a number of challenges and opportunities for the Australian pharmaceuticals industry, according to this report, which makes a series of recommendations for government policy. Currently, the industry employs 40 000 people, exhibits an R&D intensity four times that of the Australian manufacturing industry, spends more than $860 million a year on R&D, has a turnover in excess of $18 billion and is Australia’s second largest manufactured export provider